WebApr 13, 2024 · Chinook Therapeutics, Inc. SEATTLE, April 13, 2024 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical … WebMar 31, 2024 · Free-Float. 94,6%. More Financials. Company. Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, …
Chinook Therapeutics NasdaqGS:KDNY Stock Report - Simply Wall St
WebApr 13, 2024 · The stock was sold at an average price of $24.54, for a total value of $613,500.00. Following the sale, the chief executive officer now directly owns 271,676 shares of the company’s stock,... WebMar 30, 2024 · KDNY Stock Overview. Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization … how to take care of your prostate
Chinook Therapeutics (NASDAQ:KDNY) Trading Up 3.2%
WebStock Information Chinook Therapeutics, Inc. Investors Stock Information Stock Quote Change Volume Today's Open Previous Close Today's High Today's Low 52 Week High 52 Week Low Stock Chart Data Provided by Refinitiv. Minimum 15 minutes delayed. IR Contact Noopur Liffick Vice President Investor Relations & Corporate Communications WebApr 14, 2024 · Chinook Therapeutics, Inc. ( NASDAQ:KDNY – Get Rating )’s share price was up 3.2% on Wednesday . The stock traded as high as $21.08 and last traded at $21.04. Approximately 109,125 shares were traded during trading, a decline of 80% from the average daily volume of 540,593 shares. The stock had previously closed at $20.38. Web2 days ago · SEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Chinook management is scheduled to participate in the following upcoming investor … how to take care of your scalp after chemo